When Pfizer has $100bn to spend and even Warren Buffett is discussing $50bn deals, a pair of Asian bids totalling $2.5bn may look like mere crumbs for bankers stuck in the boondocks of the merger world. But the deals in question – a southeast Asian offer for Australia’s Goodman Fielder last week and a Chinese approach this week for Aquila Resources from the same country – suggest the stirrings of Asia’s own animal spirits.
当辉瑞(Pfizer)准备拿出1000亿美元进行收购，甚至沃伦•巴菲特(Warren Buffett)也在讨论500亿美元的交易时，两笔总额为25亿美元的亚洲交易，看起来或许只是给困在并购世界边缘地带的银行家们准备的“面包屑”。但这两笔拟议中的交易表明，亚洲自己的动物精神在觉醒。这两笔交易分别是一家东南亚企业对澳大利亚Goodman Fielder的拟议收购，以及一家manbetx3.0 公司对澳大利亚Aquila Resources的拟议收购。
您已阅读9%（642字），剩余91%（6280字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。